Platelet-Activating Factor

A Possible Role in the Modulation of the Vasomotor Tone and Blood Pressure
  • Rodrigo A. B. Lopes-Martins
  • Claudia V. Araújo
  • Vanessa Estato
  • Sheila Moreira
  • Renato S. B. Cordeiro
  • Eduardo V. Tibiriçá
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 416)

Abstract

It is well known that the vascular smooth muscle tone is regulated not only by the activity of the sympathetic nervous system, but also by the release of vasoactive factors from the endothelium including nitric oxide (NO), prostacyclin, thromboxane A2 and endothelin (1; 2; 3) that can be induced by both chemical and mechanical stimuli (4). In addition, several studies have reported endothelium-independent vasodilator responses to an unknown endogenous mediator, in rabbit and rat resistance arteries (5;6). PAF is a potent phospholipid mediator released by various cell types including platelets, leukocytes, macrophages, endothelial cells (7) and cultured rat vascular smooth muscle cells (8). This mediator has many biological actions already described (9). Several reports have demonstrated that PAF (<1 μg kg−1, i.v.) induce severe cardiovascular alterations, including a decrease in arterial blood pressure (10; 11), a direct negative chronotropic effect (12; 13) and an increase in vascular permeability (14). The hypotensive effect of PAF has been attributed mainly to the dilation of resistance vessels (15;16), thus suggesting a role for this mediator in the modulation of vascular smooth muscle tone.

Keywords

Mean Arterial Pressure Systemic Vascular Resistance Carotid Artery Occlusion Carotid Occlusion Vascular Smooth Muscle Tone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Furchgott, R.F. (1983). Role of endothelium in response of vascular smooth muscle. Circ. Res., 53, 557–573.PubMedCrossRefGoogle Scholar
  2. 2.
    Vane, J. (1993). Control of the circulation by endothelial mediators. Int. Arch. Allergy Immunol., 101, 333–345.PubMedCrossRefGoogle Scholar
  3. 3.
    Bevan, J.A. and Henrion, D. (1994). Pharmacological implications of the flow-dependence of vascular smooth muscle tone. Annu. Rev. Pharmacol. Toxicol., 34, 173–190.PubMedCrossRefGoogle Scholar
  4. 4.
    Kuo, L.I.H., Chilian, W.H., Davis, M.J. (1991). Interaction of pressure-and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol., 260, H1706 - H1715.Google Scholar
  5. 5.
    Gaw, A.J. and Bevan, J.A. (1993). Flow-induced relaxation of the rabbit middle cerebral artery is composed of both endothelium-dependent and -independent components. Stroke, 24, 105–110.PubMedCrossRefGoogle Scholar
  6. 6.
    Rees, D.D, Cellek, S., Palmer, R.M.J. and Moncada, S. (1990). Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the effects on vascular tone. An insight into endotoxin shock. Biochem. Biophys. Res. Commun., 173, 541–547.PubMedCrossRefGoogle Scholar
  7. 7.
    Cordeiro, R.S.B., Martins, M.a. and Silva, P.M.R. (1988). Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement. Prog. Biochem. Pharmacol., 22, 156–167.PubMedGoogle Scholar
  8. 8.
    Tomlinson, P.R., Croft, K., Harris, T. and Stewart, A.G. (1994). Platelet-activating factor biosynthesis in rat vascular smooth muscle cells. J. Vase. Res., 31, 144–152.CrossRefGoogle Scholar
  9. 9.
    Braquet, P., Touqui, L., Shen, T.Y. and Vargaftig, B.B. (1987). Perspectives in platelet-activating factor research. Pharmacol. Rev., 39, 97–145.PubMedGoogle Scholar
  10. 10.
    Caillard, C.G., Mondot, S., Zundel, J.L. and Julou, L. (1982). Hypotensive activity of PAF-acether in rats. Agents Actions, 12, 725–730.PubMedCrossRefGoogle Scholar
  11. 11.
    Felix, S.B., Baumann, G., Raschke, P., Maus, C. and Berdel, W.E. (1990). Cardiovascular reactions and respiratory events during platelet activating factor-induced shock. Basic Res. Cardiol., 85, 217–226.PubMedCrossRefGoogle Scholar
  12. 12.
    Sybertz, E.J., Watkins, R.W., Baum, T., Pula, K. and Rivelli, M. (1985). Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. J. Pharmacol. Exp. Ther., 232, 156–162.PubMedGoogle Scholar
  13. 13.
    Robertson, D.a., Genovese, a. and Levi, R. (1987). Negative inotropic effect of platelet-activating factor in human myocardium: A pharmacological study. J. Pharmacol. Exp. Ther. 243: 834–839.PubMedGoogle Scholar
  14. 14.
    Macmanus, L.M., Hanahan, D.J., Demopoulos, C.a. and Pinckard, R.N. (1980). Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J. Immunol., 124, 2919–2924.Google Scholar
  15. 15.
    Blank, M.L., Snyder, F., Byers, L.W., Brooks, B., Muirhead, E.E. (1979). Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun., 90: 1194–1200.PubMedCrossRefGoogle Scholar
  16. 16.
    Yamanaka, S., Katsuyuki, M., Yukimura, T., Okumura, M., Yamamoto, K. (1992). Putative mechanisms of hypotensive action of platelet-activating factor in dogs. Circ. Res. 70: 893–901.PubMedCrossRefGoogle Scholar
  17. 17.
    Benveniste, J., Henson, P.M. and Cochrane, C.J. (1972). Leukocyte-dependent histamine release from rabbit platelets: The role of IgE basóphils and a platelet-activating factor. J. Exp. Med., 136, 1356–1377.PubMedCrossRefGoogle Scholar
  18. 18.
    Braquet, P. and Hosford, D. (1991). Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. Ethnopharmacol., 32, 135–139.CrossRefGoogle Scholar
  19. 19.
    Casals-Stenzel, J., Muacevic, G. and Weber, K.-H. (1987). Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J. Pharmacol. Exp. Ther., 241, 974–981.PubMedGoogle Scholar
  20. 20.
    Castro-Faria-Neto, H.C., Araújo, C.V., Moreira, S., Bozza, P.T., Thomas, G., Barbosa-Filho, J.M., Cordeiro, R.S.B. and Tibiriçâ, E. (1995): Yangambin, a new naturally-occurring platelet-activating factor receptor antagonist: in vivo pharmacological studies. Planta Medica, 61, 106–112.PubMedCrossRefGoogle Scholar
  21. 21.
    Vargaftig, B.B. and Hai, N.D. (1972). Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin. J. Pharm. Pharmacol., 24, 159–161.PubMedCrossRefGoogle Scholar
  22. 22.
    Blackwell, G.J., Duncombe, W.G., Flower, R.J., Parsons, M.F. and Vane, J.R. (1977). The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs. Br. J. Pharmacol., 59, 353–366.PubMedCrossRefGoogle Scholar
  23. 23.
    Henson, P., Barnes, P. and Banks-Schlegel, S.P. (1992). Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis., 145, 726–731.PubMedCrossRefGoogle Scholar
  24. 24.
    Tramposch, K.M., Chilton, F.H., Stanley, P.L., Franson, R.C, Havens, M.B., Nettleton, D.O., Davern, L.B., Darling, I.M. and Bonney, R.J. (1994). Inhibitor of phospholipase AZ blocks eicosanoid and platelet-activating factor biosynthesis and has topical anti-inflammatory activity. J. Pharmacol. Exp. Ther., 271, 852–859.PubMedGoogle Scholar
  25. 25.
    Rao, G.N., Lassegue, B., Alexander, R.W. And Griendlling, K.K. (1994). Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem. J., 299, 197–201.PubMedGoogle Scholar
  26. 26.
    Novakova, O., Drnkova, J., Kubista, V. Novak, F. (1994). Regulation of phospholipid degradation and biosynthesis in the heart by isoprenaline: effect of mepacrine. Physiol. Res., 43, 151–156.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Rodrigo A. B. Lopes-Martins
    • 1
  • Claudia V. Araújo
    • 1
  • Vanessa Estato
    • 1
  • Sheila Moreira
    • 1
  • Renato S. B. Cordeiro
    • 1
  • Eduardo V. Tibiriçá
    • 1
  1. 1.Departamento de Fisiologia e FarmacodinâmicaInstituto Oswaldo CruzRio de JaneiroBrasil

Personalised recommendations